Literature DB >> 4564288

Role of a protease in natural activation of Clostridium botulinum neurotoxin.

B R Das Gupta, H Sugiyama.   

Abstract

All tested proteolytic Clostridium botulinum type A, B, and F strains and certain non-proteolytic B and F cultures produced a protease having trypsin-like substrate specificity; none of the tested type E (non-proteolytic) strains produced the enzyme. Progenitor toxin (toxic form whose specific toxicity is increased by treatment with trypsin) was found in culture fluid concentrates of all strains not producing the protease; it was also present in some concentrates that had the enzyme. Activation of highly purified type E progenitor toxin (molecular weight 150,000) by essentially pure protease from a proteolytic type B culture was always less than that obtained with trypsin. The product of the type E progenitor toxin-protease reaction increased in toxicity when further treated with trypsin. Results suggest that at least two bonds are cleaved by trypsin during activation of type E progenitor toxin to toxin (form manifesting maximal possible specific toxicity). Natural activation of progenitor toxin of proteolytic strains may also involve cleavage of more than one bond.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564288      PMCID: PMC422579          DOI: 10.1128/iai.6.4.587-590.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Physiology of toxin production by Clostridium botulinum types A and B. IV. Activation of the toxin.

Authors:  P F BONVENTRE; L L KEMPE
Journal:  J Bacteriol       Date:  1960-01       Impact factor: 3.490

2.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

3.  Dependence of time to death on molecular size of botulinum toxin.

Authors:  C Lamanna; L Spero; E J Schantz
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

4.  Isolation and characterization of a protease from Clostridium botulinum type B.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Biochim Biophys Acta       Date:  1972-06-16

5.  Isolation and taxonomic significance of bacteriophages for non-proteolytic Clostridium botulinum.

Authors:  H Sugiyama; G J King
Journal:  J Gen Microbiol       Date:  1972-05

6.  Botulinal toxins and the problem of nomenclature of simple toxins.

Authors:  C Lamanna; G Sakaguchi
Journal:  Bacteriol Rev       Date:  1971-09

7.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

8.  Activation of Clostridium botulinum type B toxin by an endogenous enzyme.

Authors:  B R DasGupta
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

  8 in total
  20 in total

1.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 2.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

3.  Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

4.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

5.  Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.

Authors:  A Datta; B R DasGupta
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

6.  A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.

Authors:  Eran Diamant; Avi Pass; Osnat Rosen; Alon Ben David; Amram Torgeman; Ada Barnea; Arnon Tal; Amir Rosner; Ran Zichel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

Review 8.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

9.  Role of caseinase from Aeromonas salmonicida in activation of hemolysin.

Authors:  R W Titball; A Bell; C B Munn
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Reductive methylation of lysine residues of botulinum neurotoxin types A and B.

Authors:  V Sathyamoorthy; B R DasGupta
Journal:  Mol Cell Biochem       Date:  1988-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.